Skip to main content

CITADEL ADVISORS LLC

Position in BCTX — BriaCell Therapeutics Corp.

CIK 1423053 MIAMI, FL

Position in BCTX

as of Jun 30, 2026 · filed Sep 2, 2026
Position Value
$0
+$0 QoQ
Shares Held
895,864
-14.6% QoQ
Ownership
10.3%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2023
8 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in BCTX Over Time

Shares Held

Position Value (USD)

Derivatives in BCTX

reported options exposure · as of Dec 31, 2024
CallValue
$77,448
CallShares
13,830
PutValue
$3,248
PutShares
580

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,150,763,744 across 435 Biotechnology names. BCTX ranks #435 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BCTX

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2025-09-30 $121,605 11,055
2024-12-31 $3,248 5,800
2024-12-31 $77,448 138,300
2024-09-30 $85,932 69,300
2024-06-30 $912 800
2024-06-30 $10,990 9,641
2024-06-30 $6,612 5,800
2024-03-31 $67,782 23,700
2024-03-31 $15,444 5,400
2024-03-31 $18,381 6,427
2023-12-31 $110,565 18,900
2023-12-31 $6,435 1,100
2023-12-31 $87,475 14,953